# A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

> **NCT00887354** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 224 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Risedronate
- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** Calcium
- **DIETARY_SUPPLEMENT:** Vitamin D

## Key facts

- **NCT ID:** NCT00887354
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887354, "A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00887354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*